BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«KIR

Below is an extended KIR research listing. Click here to return to the KIR main in depth entry.

Recent Publications on KIR:

Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.
To determine whether killer cell immunologlobulin-like receptor (KIR)...
Direct Link
30th August, 2008
Division of Rheumatology, Centre for Prognosis studies in the Rheumatic
Differential recognition of MHC class I molecules of xeno-/allo-endothelial cells by human NK cells.
Using human umbilical vein endothelial cells (HUVEC) and porcine aortic...
Direct Link
30th August, 2008
State Key Lab of Biomembrane and Membrane Biotechnology, Institute of
A carboxy-terminal inter-helix linker as the site of phosphatidylinositol 4,5-bisphosphate action on Kv7 (M-type) K+ channels.
The regulation of M-type (KCNQ [Kv7]) K(+) channels by...
Direct Link
30th August, 2008
Department of Physiology, MS 7756, University of Texas Health Science
Calcitonin gene-related peptide inhibits angiotensin II-mediated vasoconstriction in human radial arteries: role of the Kir channel.
OBJECTIVE: The radial artery is increasingly used for coronary artery...
Direct Link
30th August, 2008
Department of Medicine, University of Melbourne, Austin Health,
[Differential Expression Levels of Killer Immunoglobin-like Receptor Genotype in Patients with Hematological Malignancies between High-risk and Standard-risk Groups.] 23rd August, 2008
Peking University Institute of Hematology, Peking University People
A dopamine-acetylcholine cascade: Simulating learned and lesion-induced behavior of striatal cholinergic interneurons.
The giant cholinergic interneurons of the striatum are tonically active...
Direct Link
22nd August, 2008
Boston University.
Functional Implications for Kir4.1 Channels in Glial Biology: From K+ Buffering to Cell Differentiation.
Astrocytes and oligodendrocytes are characterized by a very negative...
Direct Link
12th August, 2008
The University of Alabama Birmingham, Department of Neurobiology & Center
Stoichiometry of Kir channels with phosphatidylinositol bisphosphate. 12th August, 2008
Department of Structural and Chemical Biology, Mount Sinai School of
Control of pH and PIP2 gating in heteromeric Kir4.1/Kir5.1 channels by H-Bonding at the helix-bundle crossing. 12th August, 2008
Institute of Physiology II, Friedrich Schiller University, Jena, Germany.
Polyamine permeation and rectification of Kir4.1 channels. 12th August, 2008
Department of Biochemistry, Universidad Central del Caribe, School of
[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China.] 9th August, 2008
Bioengineering College, Dalian University, Dalian 116622, China.
Extracellular domain alterations impact surface expression of stimulatory natural killer cell receptor KIR2DS5.
In the human killer cell immunoglobulin-like receptors, KIR2DL2, and...
Direct Link
7th August, 2008
Department of Oncology, Lombardi Cancer Center, Georgetown University,
Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation.
Initial molecular events leading to natural killer lymphocyte (NK) and...
Direct Link
7th August, 2008
INSERM U645, EFS Bourgogne Franche Comte, universite de Franche Comte,
NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.
BACKGROUND: Laboratory techniques used to determine haplotypes are often...
Direct Link
7th August, 2008
Department of Electronics and Information Technology, Institute of
Role of KIRs and KIR ligands in hematopoietic transplantation.
This review focuses on recent research demonstrating the role alloreactive...
Direct Link
5th August, 2008
Division of Haematology and Clinical Immunology, Department of Clinical
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional